1. Home
  2. PDLB vs ARVN Comparison

PDLB vs ARVN Comparison

Compare PDLB & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

N/A

Current Price

$20.72

Market Cap

481.1M

Sector

N/A

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$9.01

Market Cap

516.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PDLB
ARVN
Founded
1960
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.1M
516.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
PDLB
ARVN
Price
$20.72
$9.01
Analyst Decision
Buy
Analyst Count
0
19
Target Price
N/A
$15.05
AVG Volume (30 Days)
63.4K
836.3K
Earning Date
04-24-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
160.87
58.84
EPS
0.71
1.70
Revenue
N/A
$262,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.13
$5.22
Revenue Growth
N/A
N/A
52 Week Low
$13.91
$6.96
52 Week High
$20.79
$14.22

Technical Indicators

Market Signals
Indicator
PDLB
ARVN
Relative Strength Index (RSI) 60.93 60.13
Support Level $19.49 $7.90
Resistance Level N/A $9.65
Average True Range (ATR) 0.46 0.39
MACD 0.01 0.07
Stochastic Oscillator 87.16 60.40

Price Performance

Historical Comparison
PDLB
ARVN

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: